#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Antisynthetase syndrome Von Hippel-Lindau disease Parkinson's disease Alveolar proteinosis Progressive familial intrahepatic cholestasis Ehlers-Danlos syndrome Neuroendocrine tumour of the lung Systemic candida Rhabdoid tumour Myelofibrosis Lymphangioma Malignant fibrous histiocytoma Oesophageal atresia Desmoplastic small round cell tumour Systemic sclerosis pulmonary More trials…

    Learn about Rare Diseases

    Hereditary motor and sensory neuropathy – Treatment Usher’s syndrome – Diagnostics Glycogen storage disease type V – Treatment Indolent systemic mastocytosis – Treatment Myxofibrosarcoma – Life with Disease Haemophilia B without inhibitors – Treatment Pituitary-dependent Cushing’s syndrome – Diagnostics Rhabdoid tumour – Diagnostics Turner’s syndrome – Diagnostics Mitochondrial myopathy – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Olive Oil, Refined Enomimeran Lumasiran MOLNUPIRAVIR Aldesleukin Nadunolimab Evencaleucel Tng462 Dotatate Ferric Derisomaltose Pyrimethamine Nilotinib Oxogluric Acid Soya Oil Abbv-668 Co-Trimoxazole Dl-Alpha-Tocopherol Alpha-Tocopherol Sodium Nitroprusside Dihydrate Db-Oto-3 More therapies…

    Learn about Your Condition

    Neoplasm malignant Arteriosclerosis Obesity Haemolytic uraemic syndrome Emphysema Breast angiosarcoma metastatic Dilated cardiomyopathy Craniotomy Partial seizures Chronic kidney disease Gastrointestinal carcinoma Adrenogenital syndrome Biliary neoplasm Systemic scleroderma Endometrial cancer stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hereditary neuropathic amyloidosis

  • Long-Term Safety and Efficacy Study of Eplontersen in Patients with Hereditary Transthyretin-Mediated Amyloid Polyneuropathy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Eplontersen
    Cyprus France Germany Italy Portugal Spain +1

  • Long-Term Safety Study of NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy or Transthyretin Amyloidosis-Related Cardiomyopathy

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hereditary neuropathic amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Single Guide Rna Targeting The Human Ttr Gene
    • Ziclumeran
    France Sweden

  • Study on NTLA-2001 for Patients with Hereditary Transthyretin Amyloidosis with Polyneuropathy

    Not recruiting

    1 1 1
    Investigated Diseases:
    • Hereditary neuropathic amyloidosis
    Investigated Drugs:
    • Single Guide Rna Targeting The Human Ttr Gene
    • Ziclumeran
    France Sweden

  • Study on the Effectiveness and Safety of Vutrisiran and Patisiran for Patients with Hereditary Transthyretin Amyloidosis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hereditary neuropathic amyloidosis
    • Cardiac amyloidosis
    Investigated Drugs:
    • Patisiran
    • Vutrisiran
    Belgium Bulgaria Cyprus Italy The Netherlands Portugal +1

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!